Related Experiment Video
Updated: Apr 20, 2026

Fabrication of Size-Controlled and Emulsion-Free Chitosan-Genipin Microgels for Tissue Engineering Applications
Published on: April 13, 2022
Liposome-loaded chitosan physical hydrogel: toward a promising delayed-release biosystem
Aurélien Billard1, Léa Pourchet1, Sébastien Malaise1
1Ingénierie des Matériaux Polymères, UMR CNRS 5223, Université Claude Bernard Lyon 1, Université de Lyon, Domaine Scientifique de la Doua, Bâtiment POLYTECH, 15 bd André Latarjet, 69622 Villeurbanne Cedex, France.
This study presents a novel hybrid biosystem for drug delivery. Phosphatidylcholine liposomes within a chitosan hydrogel demonstrate delayed release of encapsulated molecules.
Area of Science:
- Biomaterials Science
- Drug Delivery Systems
- Polymer Chemistry
Background:
- Developing advanced drug delivery systems is crucial for improving therapeutic efficacy.
- Liposomes and hydrogels are widely investigated for controlled release applications.
- Chitosan hydrogels offer biocompatibility and biodegradability for biomedical uses.
Purpose of the Study:
- To create and characterize an innovative hybrid biosystem for delayed drug release.
- To evaluate the encapsulation and release profile of a model drug within the hybrid system.
- To demonstrate the role of liposomes in achieving sustained release within a chitosan matrix.
Main Methods:
- Fabrication of a hybrid system comprising phosphatidylcholine liposomes within a chitosan physical hydrogel.
- Characterization of the hydrogel matrix using rheological measurements.
- Visualization of liposome integration using fluorescence and cryo-scanning electron microscopy.
- Assessment of delayed-release using carboxyfluorescein (CF) as a model drug.
Main Results:
- Successful formation of the chitosan hydrogel with entrapped liposomes, confirmed by rheology.
- Liposome presence within the hydrogel matrix verified by microscopy techniques.
- Demonstrated significantly delayed release of carboxyfluorescein from liposomes-in-hydrogel compared to hydrogel-only systems.
- The hybrid system effectively controlled the release rate of the encapsulated model drug.
Conclusions:
- The developed hybrid biosystem, integrating liposomes into chitosan hydrogels, is a promising platform for delayed drug delivery.
- The lipid vesicles play a key role in modulating and sustaining the release of active pharmaceutical ingredients.
- This innovative system holds potential for advanced biomedical applications requiring controlled and prolonged therapeutic agent release.
More Related Videos
08:59A Freeze-Thawing Method to Prepare Chitosan-Polyvinyl alcohol Hydrogels Without Crosslinking Agents and Diflunisal Release Studies
Published on: January 14, 2020
08:05Preparation of Chitosan-based Injectable Hydrogels and Its Application in 3D Cell Culture
Published on: September 29, 2017
Related Concept Videos
Oral Drug Delivery Systems: Delayed-Release Systems
Modified-Release Drug Delivery Systems: Stimuli-Activated
Modified-Release Drug Delivery Systems: Rate-Programmed II
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
Modified-Release Drug Delivery Systems: Rate-Programmed I
Oral Drug Delivery Systems: Continuous-Release Systems